Screening Pap Smears and Pelvic Examinations for Early Detection of Cervical or Vaginal Cancer | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for screening Pap smears and pelvic examinations for early detection of cervical or vaginal cancer, effective May 15, 2026. Here's what changes for billing teams.

The Centers for Medicare & Medicaid Services (CMS) updated its long-standing CMS screening Pap smear and pelvic examination coverage policy governing preventive gynecologic screening services. This policy directly affects OB/GYN practices, federally qualified health centers, and any provider billing Medicare for women's preventive screening services. The policy document does not list specific CPT or HCPCS codes in the available data — but make no mistake, the underlying billing guidelines for these services have real financial exposure for your practice if you're not current on the requirements.

Quick-Reference Table

CMS Screening Pap Smear and Pelvic Examination Coverage Criteria and Medical Necessity Requirements 2026

Medicare covers screening Pap smears and pelvic examinations as preventive benefits under specific statutory criteria. Understanding exactly who qualifies — and how often — is where claim denial risk concentrates.

Under the CMS coverage policy, Medicare covers one screening Pap smear and one pelvic examination every 24 months for women who are not at high risk for cervical or vaginal cancer. That's every two years, not annually. If your billing team is submitting claims annually for standard-risk patients, you're generating denials.

For women at high risk, Medicare covers these screenings every 12 months. High-risk status is a specific clinical determination — not a blanket label your team applies at registration. Risk factors that qualify a patient for annual coverage include:

The medical necessity determination here is straightforward: if the patient is standard risk, 24-month frequency applies. If high risk, 12-month frequency applies. Document the specific risk factor in the medical record before the claim goes out. The payer will not assume high-risk status — your documentation has to establish it.

Medicare also covers a clinical breast examination as part of the pelvic exam benefit, performed in conjunction with the pelvic exam. This combination is what generates the most confusion on the billing side, because the services bundle together under Medicare's preventive benefit structure.

Prior authorization is not required for these screenings under Medicare's standard benefit. However, coverage still requires that the services are ordered by — or provided under the supervision of — a physician, physician assistant, nurse practitioner, certified nurse midwife, or clinical nurse specialist. Billing without the correct ordering or supervising provider documented is a fast path to claim denial.

Reimbursement under this policy flows through Medicare Part B as a preventive benefit. That means Medicare waives the Part B deductible and pays 100% of the approved amount — no cost-sharing for the patient. Your billing team should confirm that claims are coded to reflect the preventive nature of the visit, not a diagnostic one, because the cost-sharing treatment differs.

Coverage Indications at a Glance

The policy data available does not include a formal indication-level breakdown with specific covered/non-covered designations. The table below reflects what the CMS coverage policy establishes based on standard Medicare statute for this benefit.

CMS Screening Pap Smear and Pelvic Examination Billing Guidelines and Action Items 2026

This policy modification takes effect May 15, 2026. That gives your billing team a defined window to get aligned. Here's what to do before that date.

CPT, HCPCS, and ICD-10 Codes for Screening Pap Smears and Pelvic Examinations Under This Policy

Covered CPT and HCPCS Codes

The policy data available for this modification does not list specific CPT or HCPCS codes. CMS did not include a code table in the source document accessible through this policy record.

For reference, screening Pap smear and pelvic examination billing typically involves a set of well-established HCPCS codes under Medicare's preventive benefit structure. However, because the policy data does not specify codes, your billing team should:

• Check the current Medicare Physician Fee Schedule for applicable HCPCS codes under the preventive gynecologic screening benefit
• Confirm applicable codes with your Medicare Administrative Contractor (MAC) for your region, since local coverage determination policies may supplement this national coverage policy
• Cross-reference the CMS benefit policy manual for the most current code assignments before submitting claims after May 15, 2026

Do not assume the codes in your current charge master are correct. Verify them directly against CMS sources before the effective date.

ICD-10-CM Diagnosis Codes

The policy data does not include ICD-10-CM codes. Appropriate diagnosis coding for screening Pap smears will depend on whether the encounter is preventive or diagnostic, and whether high-risk status applies. Confirm code selection with your coding team based on current ICD-10-CM guidelines and any MAC-issued local coverage determinations in your region.

A Note on Local Coverage Determinations and Regional Variation

This is a national coverage policy from CMS. But your MAC may have a local coverage determination that applies additional criteria or documentation requirements on top of the national policy. Check with your specific MAC — whether that's Novitas, CGS, WPS, Palmetto, or another — to confirm whether a local LCD exists for screening gynecologic services in your jurisdiction.

If an LCD exists and conflicts with the national policy, the more restrictive policy applies to your claims. This is not a situation where the national policy protects you from a more stringent local rule.